58 related articles for article (PubMed ID: 1718472)
41. Synthesis, biological activity, and conformational analysis of [pGlu6,N-MePhe8,Aib9] substance P (6-11): a selective agonist for the NK-3 receptor.
Tallon M; Ron D; Halle D; Amodeo P; Saviano G; Temussi PA; Selinger Z; Naider F; Chorev M
Biopolymers; 1993 Jun; 33(6):915-26. PubMed ID: 7686410
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
43. Replacement of phe(8) in substance P by tyr (Tyr(8)-SP) alters the conformation of the peptide in DMSO, water, and lipid bilayers.
Patel AB; Srivastava S; Coutinho E; Phadke RS
Biopolymers; 1999 Nov; 50(6):602-12. PubMed ID: 10508963
[TBL] [Abstract][Full Text] [Related]
44. Backbone cyclization of the C-terminal part of substance P. Part 1: The important role of the sulphur in position 11.
Bitan G; Zeltser I; Byk G; Halle D; Mashriki Y; Gluhov EV; Sukhotinsky I; Hanani M; Selinger Z; Gilon C
J Pept Sci; 1996; 2(4):261-9. PubMed ID: 9231334
[TBL] [Abstract][Full Text] [Related]
45. Structural analysis of substance P using molecular dynamics and NMR spectroscopy.
Corcho FJ; Salvatella X; Canto J; Giralt E; Perez JJ
J Pept Sci; 2007 Nov; 13(11):728-41. PubMed ID: 17847018
[TBL] [Abstract][Full Text] [Related]
46. Toward nonpeptidal substance P mimetic analogues: design, synthesis, and biological activity.
Chorev M; Roubini E; Gilon C; Selinger Z
Biopolymers; 1991 May; 31(6):725-33. PubMed ID: 1718472
[TBL] [Abstract][Full Text] [Related]
47. [A turning point in the knowledge of the structure-function-activity relations of elastin].
Alix AJ
J Soc Biol; 2001; 195(2):181-93. PubMed ID: 11727705
[TBL] [Abstract][Full Text] [Related]
48. [Substance P--structure and action].
Bienert M
Patol Fiziol Eksp Ter; 1984; (3):71-3. PubMed ID: 6206458
[No Abstract] [Full Text] [Related]
49. [Substance P].
Matsubayashi S; Tamai H; Yanaihara N
Nihon Rinsho; 1995 Mar; 53 Su Pt 2():631-5. PubMed ID: 8753320
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
